Edition:
United Kingdom

People: Apellis Pharmaceuticals Inc (APLS.OQ)

APLS.OQ on NASDAQ Stock Exchange Global Select Market

27.00USD
13 Sep 2019
Change (% chg)

$-1.20 (-4.26%)
Prev Close
$28.20
Open
$28.20
Day's High
$28.59
Day's Low
$26.75
Volume
199,866
Avg. Vol
145,068
52-wk High
$33.18
52-wk Low
$11.45

Sadr, Ahmad 

Mr. Ahmad Sadr is Senior Vice President -Technical Operations of the Company. He has served as our Senior Vice President -Technical Operations since April 2019, having served as our Vice President – Technical Operations from January 2017 to April 2019. From May 2016 to January 2017 he served as Director – Outsourced Manufacturing at Portola Pharmaceuticals, a public biotechnology company, leading critical aspects of outsourced drug substance manufacturing. From April 2015 to May 2016 he served as Vice President – Technical Operations at Vision Medicines, a private biotechnology company, and from December 2004 to April 2015 he held various leadership roles in manufacturing and supply chain at Genentech, a public biotechnology company, including as Associate Director, Manufacturing Science and Technology from June 2014 to April 2015 and Associate Director, Global External Manufacturing from February 2012 to June 2014, with responsibility for global manufacturing of development and commercial stage biologics and pharmaceutical drugs. Mr. Sadr received his B.S. in Chemical Engineering from the University of Maryland and his M.S. in Chemical Engineering at Widener University.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --